CARBIOS: Half-year 2024 financial results show a loss of €18.1 million
- Construction progress of world’s first PET enzymatic biorecycling plant in France: in line with production targets in 2026
- Commercial development: several Letters of Intent signed in view of licensing agreements
- Consolidated cash position of €120.7 million on 30 June 2024, plus €23.4 million in term deposits classified as financial assets. In addition, €42.5 million in public funding is expected.
CARBIOS, a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, reported its operating and financial results for the first half of 2024.
The financial statements as of 30 June 2024 were approved by CARBIOS' Board of Directors.
The improvement in the financial results is mainly due to the increase in the Company’s financial income from interest on money market investments and term deposits of its cash and cash equivalents. Cash is systematically invested in risk-free, highly liquid money market products.
The decrease in financial expenses is mainly due to the capitalization of borrowing costs for the Longlaville plant.
The Group’s operating income (loss) shows a loss of €18.1 million at 30 June 2024 (€13.7 million loss at 30 June 2023).
The Group’s cash position stands at €120.7 million at 30 June 2024, plus
€23.4 million in term deposits classified as financial assets (for a total cash of €144 million after incorporation of term deposits) (€192 million at 31 December 2023).
On the basis of cashflow position to date, and the Company’s forecast operating expenses, CARBIOS considers to be able to cover its needs beyond the next 12 months. In addition, €42.5 million euros in public funding is expected.
In the first six months of 2024:
- The Group incurred €11,771 thousand in R&D expenses. The rise in R&D costs is mainly due to increased staff costs in line with the development of the Group’s various activities.
- The Group reported €1,952 thousand of Subsidies and other business income, which partially offset these R&D expenses. This item mainly consists of €1,379 thousand in tax credit for first-half 2024, of which €1,043 thousand relates to CARBIOS and €336 thousand to Carbiolice.
Finally, the Group continued to capitalize the Development expenses of its PET biorecycling project, booking a total €1,618 thousand in the first half of 2024, in accordance with IAS 38 capitalization criteria.
During this first period of the 2024 financial year, CARBIOS forged several international strategic partnerships with a view to deploying its licensing model for its technology and know-how in the field of PET plastic and textile enzymatic biorecycling.
Carbios